REXAHN PHARMACEUTICALS (RNN) Covered Calls

You can sell covered calls on REXAHN PHARMACEUTICALS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for RNN (prices last updated Tue 1:30 PM ET):

REXAHN PHARMACEUTICALS (RNN) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.05 -0.04 1.05 1.06 270K - 0.0B
Covered Calls For REXAHN PHARMACEUTICALS (RNN)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 2.5 0.00 1.06 0.0% 0.0%
Dec 21 2.5 0.00 1.06 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes treatments for cancer. The company's clinical stage drug candidates include RX-3117, which is in Phase II a clinical trial for the treatment of patients with relapsed or refractory pancreatic cancer and advanced bladder cancer; and Supinoxin that is in Phase II a clinical study to treat patients with metastatic triple negative breast cancer. Rexahn Pharmaceuticals, Inc. is based in Rockville, Maryland.